Tianjin Medical University General Hospital
🇨🇳China
Eculizumab for Acute Attack of Neuromyelitis Optica Spectrum Disorder
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-11-04
- Last Posted Date
- 2024-11-04
- Lead Sponsor
- Tianjin Medical University General Hospital
- Target Recruit Count
- 75
- Registration Number
- NCT06673394
Identify the State of Laminae Milling by Sound
Completed
- Conditions
- First Posted Date
- 2024-10-30
- Last Posted Date
- 2024-10-30
- Lead Sponsor
- Tianjin Medical University General Hospital
- Target Recruit Count
- 6
- Registration Number
- NCT06665360
- Locations
- 🇨🇳
Tianjin Medical University General Hospital, Tianjin, Tianjin, China
Safety and Efficacy of BAFFR CART for Relapsed/ Refractory Neuromyelitis Optica Spectrum Disorder
Phase 1
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-08-19
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Tianjin Medical University General Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06561009
Efficacy and Safety of Baricitinib in the Post-intracerebral Hemorrhage Pulmonary Injury
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-08-12
- Last Posted Date
- 2024-08-12
- Lead Sponsor
- Tianjin Medical University General Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT06548802
- Locations
- 🇨🇳
Tianjin Medical University General Hospital, Tianjin, Tianjin, China
FcRn Antagonists (Efgartigimod) for Acute NMOSD Attack
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-07-11
- Last Posted Date
- 2024-07-11
- Lead Sponsor
- Tianjin Medical University General Hospital
- Target Recruit Count
- 63
- Registration Number
- NCT06497374
Safety and Efficacy of Tocilizumab in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-06-11
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- Tianjin Medical University General Hospital
- Target Recruit Count
- 102
- Registration Number
- NCT06452537
- Locations
- 🇨🇳
Tianjin Medical University General Hospital, Tianjin, Tianjin, China
The Effect of Esketamine on Sleep Disturbance
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-04-29
- Last Posted Date
- 2024-05-01
- Lead Sponsor
- Tianjin Medical University General Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT06388824
- Locations
- 🇨🇳
Tianjin medical university general hospital, Tianjin, China
🇨🇳Tianjin Medical University General Hospital, Tianjin, China
Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma
- First Posted Date
- 2024-03-25
- Last Posted Date
- 2024-03-25
- Lead Sponsor
- Tianjin Medical University General Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT06327451
- Locations
- 🇨🇳
Tianjin Medical University General Hospital, Tianjin, China
Efficacy and Safety of Liposomal Bupivacaine Under ERAS Concept for Postoperative Analgesia of Ultrasound-Guided QLB in Gynecologic Laparoscopic Patients: A Randomized, Single-blind, Active-Controlled Clinical Study
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-03-01
- Last Posted Date
- 2024-03-01
- Lead Sponsor
- Tianjin Medical University General Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT06288841
- Locations
- 🇨🇳
Tianjin Medical University General Hospital, Tianjin, Tianjin, China
Esketamine vs Remimazolam for Postoperative Sleep Disturbance and Anxiety
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-02-29
- Last Posted Date
- 2024-03-05
- Lead Sponsor
- Tianjin Medical University General Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT06284668
- Locations
- 🇨🇳
Tianjin Medical University General Hospital, Tianjin, China
© Copyright 2024. All Rights Reserved by MedPath